Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review

BACKGROUND: Rofecoxib is a cyclo-oxygenase 2 selective inhibitor. This systematic review of rofecoxib in acute pain examined studies in adults of analgesic efficacy over six hours, the amount and quality of the evidence on extended duration of analgesia, and the quality and quantity of evidence on a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barden, Jodie, Edwards, Jayne E, McQuay, Henry J, Moore, R Andrew
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC116676/
https://www.ncbi.nlm.nih.gov/pubmed/12069696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC116676/
https://www.ncbi.nlm.nih.gov/pubmed/12069696

Ejemplares similares